A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma

NCT02805179 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Glioma

Interventions

RADIATION: High Dose Radiation
DRUG: Temozolomide

Sponsor

University of Michigan Rogel Cancer Center